RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations
Current Drug Target -Cardiovascular & Hematological Disorders · 2003
DOI: 10.2174/1568006033337258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Cardiovascular & Hematological Disorders, 2003. Verfasst von Annemieke Smit-van Oosten und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University Hospital Groningen, The Netherlands. a.smit-van.oosten@med.rug.nl. Hauptthemen laut MEDLINE: Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University Hospital Groningen, The Netherlands. a.smit-van.oosten@med.rug.nl
Zitieren
APA
Smit-van Oosten, A., Stegeman, C. A., & van Goor, H. (2003). RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations. Current Drug Target -Cardiovascular & Hematological Disorders. https://doi.org/10.2174/1568006033337258
Vancouver
Smit-van Oosten A, Stegeman CA, van Goor H. RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations. Current Drug Target -Cardiovascular & Hematological Disorders. 2003. doi:10.2174/1568006033337258
BibTeX
@article{SmitvanOosten2003,
author = {Smit-van Oosten, Annemieke and Stegeman, Coen A and van Goor, Harry},
title = {RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations},
journal = {Current Drug Target -Cardiovascular & Hematological Disorders},
year = {2003},
doi = {10.2174/1568006033337258}
}
EUVIMED